MDB Capital Holdings, LLC (MDBH)
| Market Cap | 18.27M -52.2% |
| Revenue (ttm) | 5.48M +135.5% |
| Net Income | -22.46M |
| EPS | -2.20 |
| Shares Out | 10.44M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 8,280 |
| Open | 1.750 |
| Previous Close | 1.970 |
| Day's Range | 1.750 - 1.750 |
| 52-Week Range | 1.750 - 4.800 |
| Beta | 1.24 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 12, 2026 |
About MDBH
MDB Capital Holdings, LLC, through its subsidiaries, primarily operates as a broker-dealer. The company operates in two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment operates as a full-service broker dealer firm, which focuses on conducting private and public security offerings, as well as providing research services for investment banking due diligence. The Technology Development segment develops a small molecule senescence platform. It provides se... [Read more]
Financial Performance
Financial StatementsNews
BioNTX and PatentVest Announce Multi-Year Strategic Partnership
Collaboration will strengthen the Rising Stars platform through structured intellectual property diligence, commercialization-focused assessments, and year-round founder support Collaboration will str...
New Patent Intelligence Report Reveals the Hidden Competitors in the Race to Build AI Smart Glasses
PatentVest's newest PV Pulse analysis finds Apple's and Microsoft's AI smart glasses–relevant patent portfolios outrank Google's, Snap's, and Samsung's — despite neither company selling an AI smart gl...
MDB Capital Holdings, LLC Earnings Call Transcript: Q2 2026
Management is focused on monetizing four core assets, maintaining lean operations, and avoiding dilution. Key milestones include a potential Public Ventures deal, a PatentVest spinout, and upcoming value inflection points for eXoZymes and Paulex Bio.
MDB Capital Holdings, LLC Quarterly report: Q2 2026
MDB Capital Holdings, LLC has published its Q2 2026 quarterly earnings report on August 13, 2026.
MDB Capital Holdings, LLC Earnings release: Q2 2026
MDB Capital Holdings, LLC released its Q2 2026 earnings on August 13, 2026, summarizing the period's financial results.
MDB Capital Holdings, LLC Slides: Q2 2026
MDB Capital Holdings, LLC has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 13, 2026.
MDB Capital Holdings Provides Second Quarter 2026 Update
Addison, TX, Aug. 13, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-defining, disruptive technology companies, pro...
MDB Capital Holdings to Host Second Quarter 2026 Update Call on Thursday August 13, 2026 at 4:30 p.m. Eastern Time
Addison, TX, July 30, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-defining, disruptive technology companies, wil...
What Is OpenAI Actually Patenting? PatentVest Pulse Analyzes OpenAI's Patent Portfolio
New PatentVest Pulse report reveals how OpenAI's published patent portfolio maps its AI product strategy across conversational AI, AI agents, generative media, developer platforms, personalization, an...
PatentVest Publishes New IP Legal Insights Article Examining Why Patent Prosecution Is Ready for AI
Dallas, TX, July 02, 2026 (GLOBE NEWSWIRE) -- PatentVest today announced the publication of a new article in its IP Legal Insights section, continuing the firm's commitment to providing practical lega...
PatentVest Releases New PatentVest Pulse Report Exploring the Strategic Shift Beyond GLP-1
Dallas, TX, June 30, 2026 (GLOBE NEWSWIRE) -- Today, PatentVest, a leading provider of IP Strategy and IP Law services, announced the release of its latest PatentVest Pulse report, "The Crossover: How...
MDB Capital Holdings, LLC Transcript: Planet MicroCap Las Vegas 2026
The presentation outlined a strategy centered on building and launching companies with foundational IP, leveraging a full-stack platform and spinning out key subsidiaries. Despite a challenging microcap environment, the team maintains a strong IPO track record and is focused on scalable, high-upside opportunities.
PatentVest to Present at Planet MicroCap Las Vegas on June 17
PatentVest Will Discuss Intellectual Property Strategy, Innovation Intelligence, and the Future of AI-Native IP Services PatentVest Will Discuss Intellectual Property Strategy, Innovation Intelligence...
New PatentVest Pulse Report Maps the Emerging Muscle-Preservation Category Expanding the GLP-1 Opportunity
• Analysis of 20 muscle-preservation programs highlights a rapidly emerging category designed to enhance long-term obesity treatment outcomes
MDB Capital to Present at Planet MicroCap Las Vegas 2026 Along with Subsidiary PatentVest and Portfolio Company Buda Juice
Addison, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC (NASDAQ: MDBH) today announced that its CEO & Co-Founder, Chris Marlett, will present live at the Planet MicroCap Las Vegas ...
PatentVest Launches New Case Studies Section Featuring Strategic AI IP Engagement with Docana
Dallas, TX, May 19, 2026 (GLOBE NEWSWIRE) -- Today, PatentVest, a leading provider of IP Strategy and IP Law services, announced the launch of a new Case Studies section on its website, beginning with...
MDB Capital Holdings, LLC Quarterly report: Q1 2026
MDB Capital Holdings, LLC has published its Q1 2026 quarterly earnings report on May 14, 2026.
New PatentVest Pulse Report Maps the Triple-Agonist Race and the Emerging Patent Battle Shaping the Post-GLP-1 Obesity Market
DALLAS, TX, May 08, 2026 (GLOBE NEWSWIRE) -- Today, PatentVest, a leading provider of IP Strategy and IP Law services, announces the release of its latest report, “The Triple-Agonist Race: Retatrutide...
Retatrutide Crosses the Surgical Threshold, but the Real Race Has Just Started
Dallas, TX, April 29, 2026 (GLOBE NEWSWIRE) -- PatentVest today released its latest PatentVest Pulse: “The Last 20%: Retatrutide, the Glucagon Paradox, and the Race to Own Surgery-Level Weight Loss Wi...
MDB Capital Holdings, LLC Earnings Call Transcript: Q4 2025
Management is optimistic about scaling company launches using AI, with four principal assets poised for significant value creation. Operating expenses are expected to decrease post-spinout of MDB Direct and PatentVest, while distribution and execution risks remain key challenges.
MDB Capital Holdings, LLC Shareholder letter: Q4 2025
MDB Capital Holdings, LLC has published a letter to shareholders covering Q4 2025, which was released on March 31, 2026.
MDB Capital Holdings, LLC Annual report: Q4 2025
MDB Capital Holdings, LLC has published its Q4 2025 annual report on March 31, 2026.
MDB Capital Holdings, LLC Slides: Q4 2025
MDB Capital Holdings, LLC has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 31, 2026.
PatentVest Releases New Pulse Report on the $19 Billion Amylin Drug Race Transforming Obesity Treatment
Dallas, TX, March 31, 2026 (GLOBE NEWSWIRE) -- PatentVest today released its latest PatentVest Pulse report, “The Amylin Renaissance: Forty Programs, $19 Billion in Deals, and the Race to Build the Ne...
PatentVest Highlights New Legal Article on AI Patenting Strategy by Senior Patent Attorney Sarah Cork
Dallas, TX, March 30, 2026 (GLOBE NEWSWIRE) -- PatentVest today announced a new addition to its IP Legal Insights section on the company website, a platform dedicated to sharing expert legal perspecti...